We are live on
!
Find out more
VFA
Values First Advisors Portfolio holdings
AUM
$192M
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
-3.45%
1 Year Est. Return
+24.96%
3 Year Est. Return
+70.52%
5 Year Est. Return
+87.3%
10 Year Est. Return
–
AUM
$155M
AUM Growth
-$10.9M
(-6.6%)
Cap. Flow
-$2.83M
Cap. Flow
% of AUM
-1.83%
Top 10 Holdings %
Top 10 Hldgs %
30.99%
Holding
183
New
13
Increased
56
Reduced
86
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medifast
MED
|
+$1.9M |
| 2 |
Mirum Pharmaceuticals
MIRM
|
+$1.04M |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$743K |
| 4 |
Toast
TOST
|
+$708K |
| 5 |
Extra Space Storage
EXR
|
+$644K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pool Corp
POOL
|
+$1.9M |
| 2 |
Doximity
DOCS
|
+$868K |
| 3 |
XIFR
XPLR Infrastructure LP
XIFR
|
+$859K |
| 4 |
Tanger
SKT
|
+$827K |
| 5 |
Generac Holdings
GNRC
|
+$763K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.91% |
| 2 | Healthcare | 14.88% |
| 3 | Industrials | 9.75% |
| 4 | Consumer Discretionary | 7.1% |
| 5 | Real Estate | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRML
176
DELISTED
Tourmaline Bio
TRML
| – | – |
-3,201
| Closed | -$97.3K |
|
177
Verisk Analytics
VRSK
$26.4B
| – | – |
-2,832
| Closed | -$640K |
|
178
WEC Energy
WEC
$37.7B
| – | – |
-3,086
| Closed | -$272K |
|
179
Zoetis
ZTS
$31.6B
| – | – |
-1,837
| Closed | -$316K |
|
|
XIFR
180
XPLR Infrastructure LP
XIFR
$1.18B
| – | – |
-14,646
| Closed | -$859K |
|
|
KDNY
181
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| – | – |
-5,609
| Closed | -$215K |
|
|
LSI
182
DELISTED
Life Storage, Inc.
LSI
| – | – |
-5,388
| Closed | -$716K |
|
|
NBRV
183
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| – | – |
-27,262
| Closed | -$41.2K |
|
Similar funds
KWM
SCGDR
KC
CVSC
CA
WIA
AGA
LFIA
Values First Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Values First Advisors held 183 positions worth $155M, down 6.6% from $166M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Values First Advisors's Q3 2023 filing shows 13 new, 56 increased, 86 reduced and 20 closed positions. Its largest new stake was Medifast: 21,430 shares worth $1.6M. The largest sale was Pool Corp, an estimated $1.9M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Industrials.
- Values First Advisors's largest Q3 2023 buy was Medifast: 21,430 shares worth $1.6M.
- Values First Advisors added most to Emergent Biosolutions in Q3 2023, an estimated $564K increase.
- Values First Advisors's biggest Q3 2023 reduction was Pool Corp, cutting an estimated $1.9M.
- Values First Advisors fully exited Doximity in Q3 2023, selling an estimated $868K.
- Values First Advisors's ten largest holdings make up 31% of its $155M portfolio in Q3 2023.
- Values First Advisors opened 13 new positions and closed 20 in Q3 2023.
- Values First Advisors's portfolio value fell 6.6% quarter-over-quarter to $155M.
Based on Values First Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.